Home
Services
Organic Synthesis
Peptide Synthesis
Antibody Production
Protein Expression
Bioconjugation Service
Immunoassay Service
Molecular Biology Services
Oligonucleotides Synthesis
RNA Synthesis Service
Polymers & Contract Manufacturing
cGMP Peptide Synthesis Services
cGMP Organic Synthesis Services
Products
Small Molecule Inhibitors and Antagonist
Bioactive Compounds and Agonist
Primary Antibodies
Catalog Peptides
Amino Acids Derivatives
Reagents
Fluorescent dyes
Intermediates
PCR
Proteasomes and Enzymes
Enzyme substrate
Nucleotides
Promotions
Customer Support
About Us
Site Map
Contact Us
Small Molecule Inhibitors and Antagonist
Anti-virus
Cell Cycle
DMPK/Tox
Endocrinology
Epigenetics
GPCR/G-protein
Mitogen-activated Protein Kinases (MAPK)
PI3K/Akt/mTOR
Proteases/Proteasome
Protein Tyrosine Kinases (PTK)
Stem Cells
TGF-Beta/Smad
Transporter
Others
Cat. No. Name Size Price Add Cart
KI0456CS-8958(Laninamivir)QuoteQuote

Chemical Characteristic

Product NameCS-8958(Laninamivir)
CAS No.203120-17-6
Molecular Weight 346.34
FormulaC13H22N4O7
Chemical Name(4S,5R,6R)-5-Acetamido-4-guanidino-6-((1R,2R)-2,3-dihydroxy-1-methoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
Chemical Structure

Biological activities

CS-8958 as the prodrug of R-125489 which is a new neuraminidase (NA) inhibitor reveals long-acting anti-influenza virus activity. CS-8958 displays comparably weak inhibitory activities against the 1934 isolate (A/PR/8/34) and the 1968 isolate (A/Aichi/2/68) with mean IC50 of 822 and 114 nM, respectively. CS-8958 basically shows no inhibitory activities against some strains of B viruses, with an IC50 of mean 10 μM. The IC50 of CS-8958 for H2N2 (A/Singapore/1/57) virus is 128 nM. However, R-125489 reveals potent NA inhibitory role with IC50s of 2.49 nM for some strains of H1N1 viruses. The mean IC50 of R-125489 against H3N2 viruses is 16.7 nM. CS-8958 has either no or weak inhibitory activities with a minimal IC50 of 142 nM against animal influenza virus subtypes N3 to N9 and H5N1 virus while the minimal IC50 of R-125489 is 1.81 nM. Mice that treated with CS-8958, have the highest survival rate, and more than half the mice given CS-8958 survived for 20 days p.i. Importantly, all mice infected with 500 PFU of A/PR/8/34 survive after three injections of CS-8958 at a dose of 0.2 μmol/kg.[1] CS-8958 at a single dose of 1,500 µg/kg which is given to mice 2 hours post-infection with H5N1 influenza viruses generates a higher survival rate than did continuous five-day injections of oseltamivir at a dose of 50 mg/kg twice daily. CS-8958 is also highly efficacious against highly pathogenic H5N1 influenza virus and oseltamivir-resistant variants. For seven days prior to virus infection, a single injection of CS-8958 also protects mice against H5N1 virus lethal infection.[2] In pharmacokinetics, after intratracheal injection of CS-8958, plasma R-125489 concentration is slowly eliminated, and its half-life (14.1 hours) is considerably longer than that after intravenous injection of R-125489. The radioactivity of intratracheally injected 14C-CS-8958 is mainly excreted into the urine (accounting for 67.5% of dose). R-125489 possessed most of the urinary radioactivity recovered after 24 hours. [3]

Protocols

CS-8958 are dissolved in distilled water .[1]

References

[1] Yamashita M, et al. CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrob Agents Chemother. 2009, 53(1): 186-192.
[2] Kiso M, et al. Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses. PLoS Pathog. 2010, 6(2): e1000786.
[3] Koyama K,et al. Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats. Xenobiotica. 2010, 40(3): 207-216.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.
About
KareBayTM Biochem
Sitemap
Blog
Custom Services
Organic Synthesis
Peptide Synthesis
Antibody Production
Protein Expression
Bioconjugation Service
Immunoassry Service
Molecular Biology Services
Oligonucleotides Synthesis
RNA Synthesis Service
cGMP Peptide Synthesis Services
cGMP Organic Synthesis Services
Biochemical Products
Small Molecule Inhibitors
Bioactive Compounds
Primary Antibodies
Peptides
Amino Acids
Reagents
Fluorescent dyes
Intermediates
PCR
Contact Us
KareBayTM Biochem, Inc.
11 Deer Park Drive, Suite 102A
Monmouth Junction, NJ 08852
Telephone
: 732-823-1545

Fax
: 732-823-1349
product@karebaybio.com
service@karebaybio.com
support@karebaybio.com
Follow Us
Follow Karebay on LinkedinFollow IMAGING on Twitter Google+ Facebook